Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.    Patients who receive an ...

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better prognosis than those who ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later – can dramatically improve their outlook and even save lives. Patients trea ...

Analysis suggests that treating heart attack patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.

A new study from Lund University in Malmö, Sweden, revealed that waist circumference is a stronger risk indicator for obesity ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not ...

Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested.

Palestinian Ambassador to Kuwait Rami Tahboub confirmed that “From Ground Zero” is the most powerful and important movie ever ...

A simpler method of analyzing blood samples for Alzheimer's disease has been tested in a large multi-center study.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...